blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4153198

EP4153198 - PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.11.2023
Database last updated on 15.06.2024
FormerRequest for examination was made
Status updated on  24.02.2023
FormerThe international publication has been made
Status updated on  26.11.2021
Formerunknown
Status updated on  04.06.2021
Most recent event   Tooltip17.11.2023Application deemed to be withdrawnpublished on 20.12.2023  [2023/51]
Applicant(s)For all designated states
RRW B.V.
Limburgstraat 2
5144 CR Waalwijk / NL
For all designated states
van de Wiel, Frederikus Gerardus Josephus Maria
Limburgstraat 2
5144 CR Waalwijk / NL
[2023/13]
Inventor(s)01 / WILDWATER, Marjolein
1704NA Heerhugowaard / NL
02 / VAN DE WIEL, Frederikus Gerardus Josephus Maria
5144 CR Waalwijk / NL
 [2023/13]
Representative(s)König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf
Mönchenwerther Straße 11
40545 Düsseldorf / DE
[2023/13]
Application number, filing date21727809.218.05.2021
[2023/13]
WO2021EP63116
Priority number, dateDE2020100294918.05.2020         Original published format: DE102020002949
[2023/13]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2021233901
Date:25.11.2021
Language:DE
[2021/47]
Type: A1 Application with search report 
No.:EP4153198
Date:29.03.2023
Language:DE
The application published by WIPO in one of the EPO official languages on 25.11.2021 takes the place of the publication of the European patent application.
[2023/13]
Search report(s)International search report - published on:EP25.11.2021
ClassificationIPC:A61K35/744, A61K31/00, A61K35/745, A61K35/747, A61P25/28
[2023/13]
CPC:
A61K35/744 (EP); A61K35/747 (EP,US); A61K31/05 (EP,US);
A61K31/12 (EP,US); A61K31/352 (EP,US); A61K35/741 (EP);
A61K35/745 (EP); A61K45/06 (EP); A61P25/28 (EP,US) (-)
C-Set:
A61K31/05, A61K2300/00 (EP);
A61K31/12, A61K2300/00 (EP);
A61K31/352, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/13]
TitleGerman:PROBIOTISCHE BAKTERIEN ZUR BEHANDLUNG DER ALZHEIMER KRANKHEIT[2023/13]
English:PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE[2023/13]
French:BACTÉRIES PROBIOTIQUES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER[2023/13]
Entry into regional phase22.11.2022National basic fee paid 
22.11.2022Designation fee(s) paid 
22.11.2022Examination fee paid 
Examination procedure22.11.2022Examination requested  [2023/13]
22.11.2022Date on which the examining division has become responsible
14.07.2023Application deemed to be withdrawn, date of legal effect  [2023/51]
03.08.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2023/51]
Fees paidPenalty fee
Additional fee for renewal fee
31.05.202303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]KR20110057550  (ILDONG PHARM CO LTD [KR]) [X] 1,2,9-15 * claims; * [Y] 3-8;
 [X]WO2013190068  (NESTEC SA [CH]) [X] 1-15 * page 5, lines 26-34; claims; *;
 [X]WO2019157585  (PROVIVA PHARMA INC [CA]) [X] 1-15 * Ex 4 on pages 32-38; claims; page 54, lines 8-12; *;
 [X]CN111096455  (UNIV ZHEJIANG SIENCE & TECHNOLOGY) [X] 1-15 * claims. example 1-3; *;
 [XY]  - JEONG J.-J. ET AL, "Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent memory impairment in Fischer 344 rats", LETTERS IN APPLIED MICROBIOLOGY, GB, vol. 60, no. 4, doi:10.1111/lam.12393, ISSN 0266-8254, (20150204), pages 307 - 314, URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Flam.12393, XP055826537 [X] 1,2,9-15 * the whole document * [Y] 3-8

DOI:   http://dx.doi.org/10.1111/lam.12393
 [XY]  - JUNG I.-H. ET AL, "Lactobacillus pentosus var. plantarum C29 protects scopolamine-induced memory deficit in mice", JOURNAL OF APPLIED MICROBIOLOGY, GB, (20120917), vol. 113, no. 6, doi:10.1111/j.1365-2672.2012.05437.x, ISSN 1364-5072, pages 1498 - 1506, XP055826543 [X] 1,2,9-15 * the whole document * [Y] 3-8

DOI:   http://dx.doi.org/10.1111/j.1365-2672.2012.05437.x
 [XY]  - NOVIK GALINA ET AL, "Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine", MICROBES AND INFECTION, ELSEVIER, PARIS, FR, vol. 22, no. 1, doi:10.1016/J.MICINF.2019.06.004, ISSN 1286-4579, (20190621), pages 8 - 18, (20190621), XP086021748 [X] 1,2,9-15 * page 14-15, chapter 7 and page 16, chapter 10; * [Y] 3-8

DOI:   http://dx.doi.org/10.1016/j.micinf.2019.06.004
 [XY]  - REZAEI ASL ZAHRA ET AL, "Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease", BEHAVIOURAL BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 376, doi:10.1016/J.BBR.2019.112183, ISSN 0166-4328, (20190828), (20190828), XP085851731 [X] 1,2,9-15 * the whole document * [Y] 3-8

DOI:   http://dx.doi.org/10.1016/j.bbr.2019.112183
 [Y]  - KLEIN THOMAS W ET AL, "Therapeutic potential of cannabinoid-based drugs", RETINAL DEGENERATIVE DISEASES: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY; [ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY ISSN 0065-2598], SPRINGER, US, (20070101), vol. 601, ISSN 0065-2598, pages 395 - 413, XP009107026 [Y] 3-8 * page 404, chapter 5.2; *
 [Y]  - SIMON WANNINGER ET AL, "Metal complexes of curcumin - synthetic strategies, structures and medicinal applications", CHEMICAL SOCIETY REVIEWS, UK, (20150101), vol. 44, no. 15, doi:10.1039/C5CS00088B, ISSN 0306-0012, pages 4986 - 5002, XP055432857 [Y] 3-8 * page 4996-4997: chapter 5.2 *

DOI:   http://dx.doi.org/10.1039/C5CS00088B
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.